Mesenchymal Stem Cells for the Treatment of COVID-19

Completed · Phase 1 · Has a placebo group

Conditions studied: Covid19, Prophylaxis

In brief

This double blind, placebo controlled, multi-arm, multi-site study investigates the safety and efficacy of stem cell therapy for the treatment of patients admitted to hospital suffering complications from COVID-19 and the treatment of healthy subjects (healthcare providers) for prophylactic effect following those patients.

Key facts

Study ID

NCT04573270

Run by

Thomas Advanced Medical LLC

People needed

40

Starts

2020-04-24

Expected to finish

2020-09-01

Last updated by the study team

2020-10-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age 18 and older
• Ability to provide informed consent

You may not qualify if…

• Active or recent malignancy (within last 2 years)
• Inability to provide informed consent
• Current enrollment in any other COVID-19 treatment study

Where it is running

• Southern California Hospital at Culver City / Southern California Hospital at Hollywood — Culver City, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.